Skip to main content
Premium Trial:

Request an Annual Quote

CuraGen Expands Novel Human Gene Database to Over 70,000 Assemblies

Premium

NEW HAVEN, Conn.--CuraGen announced the expansion of its proprietary database to include more than 70,000 novel human sequences, organized into large gene segments or assemblies, that are not publicly available. The database will serve as the basis for developing protein therapeutic drugs, human antibody drug targets, and for identifying small molecule drug targets. CuraGen researchers will also use the data to mine public databases for data useful in assembling full-length genes and discovering additional drug targets.

In other news, in collaboration with Glaxo Wellcome, CuraGen has completed a research program investigating biological pathways that may be associated with Alzheimer's disease. The completion of the research triggers an undisclosed payment to CuraGen. "CuraGen's ability to precisely evaluate differential gene expression in specific tissues has provided Glaxo Wellcome with greater insight into Alzheimer's disease," said Allen Roses, Glaxo's vice-president and worldwide director of genetics.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.